Wolters Kluwer buys US-based Invistics and its Flowlytics software
Invistics’ Flowlytics solution utilises predictive analytics to identify illicit diversion of both controlled and non-controlled medications in patient…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
08 Jun 23
Invistics’ Flowlytics solution utilises predictive analytics to identify illicit diversion of both controlled and non-controlled medications in patient…
07 Jun 23
Together with its gene therapy unit AskBio, Bayer will access Acuitas’ high-potency ionisable lipid technology and LNP carriers,…
07 Jun 23
The new range of products is intended to help researchers to tap into the potential of birth tissues…
07 Jun 23
Curi Bio has designed the MantaReady iPSC-derived skeletal muscle myoblasts for preclinical therapeutic discovery, high-throughput screening, and disease…
07 Jun 23
The new facility will be the eighth in Colorcon's global network; and will produce high-quality and innovative film…
07 Jun 23
This strategic move will help CitiusTech expand its global delivery model through its foray into the European market,…
07 Jun 23
Scheduled to open in July 2023, the new regional commercial office located in Minato, Tokyo, will be part…
06 Jun 23
Abbott, Real Madrid and the Real Madrid Foundation launch 'Beat Malnutrition' campaign as part of a sustained collaboration…
06 Jun 23
Vazyme (688105.SH), China's leading biotechnology company, has officially signed a global strategic cooperation agreement with Azenta Life Sciences…
06 Jun 23
The Matrix-M adjuvant is a key component of Novavax's COVID vaccine and its development-stage vaccines including influenza and…